Cipralex escitalopram: Phase III; Under review in the U.S. and approved in Europe

Subset analysis of a 170-patient subgroup in a Phase III trial in a total of 357 patients showed a response

Read the full 202 word article

How to gain access

Continue reading with a
two-week free trial.